Vandervoort Adam C's Form 4 filing
Teladoc Health, Inc. (TDOC) · filed Sep 6, 2023
- Accession no.
- 0001477449-23-000044
- Filed
- Sep 6, 2023
- Trade date
- Sep 1-5, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $22.0K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vandervoort Adam CCIK 0001375088 | Officer (CHIEF LEGAL OFFICER, SECRETARY) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2023 | Common Stock | MOption exerciseAcquired | +1,881 | –F1 | – | 23,512 | Direct | |
| Sep 5, 2023 | Common Stock | SSaleDisposed | −961 | $22.89 | −$21,997.29 | 22,551 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2023 | Common Stock | MOption exerciseDisposed | −1,881 | $0.00 | $0 | 11,286 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 1 transaction in Table I.